---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-031337"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2026-09-28T20:01:53+00:00"
generated_at: "2026-10-12T13:34:40.260693+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Phio holders approve 1.5M-share increase to 2020 incentive plan; all six directors elected

## Summary
- Stockholders approved Amendment No. 1 raising shares issuable under the 2020 Long Term Incentive Plan by 1,500,000, to a total of 2,452,017 shares.
- Plan amendment passed with 1,155,945 votes for, 194,070 against, 34,468 abstained and 3,823,097 broker non-votes.
- All six directors elected to serve until the 2027 annual meeting; Robert J. Bitterman received 1,341,217 for and 43,266 withheld.
- Grant Thornton LLP ratified as independent auditor for fiscal 2026 by 5,087,608 for to 88,779 against; 31,193 abstained.
- 11,617,250 shares were outstanding as of the August 4, 2026 record date; 5,207,580 shares were represented at the September 28, 2026 meeting.

## SEC filing metadata
- accession: 0001437749-26-031337
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2026-09-28T20:01:53+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000143774926031337/0001437749-26-031337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000143774926031337/phio20260916_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-031337
- JSON: https://secwatch.observer/filing/0001437749-26-031337.json
- Plain text: https://secwatch.observer/filing/0001437749-26-031337.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.